Our mice models showed that circ-GALNT16 overexpression could inhibit the proliferation and metastatic ability of CRC in vivo, thus indicating that circ-GALNT16 might have the potential to act as a therapeutic target for CRC. The gene discussed is GALNT16; the disease is colorectal carcinoma.